MyFinsight
Home
Blog
About
Inventory
$1,306,302
(25.18%↑ Y/Y)
Goods and services tax
receivable
$19,344
(-16.64%↓ Y/Y)
Accounts receivable
$6,811
(-94.04%↓ Y/Y)
Cash
$555
(-96.73%↓ Y/Y)
Right-of-use building, net
$5,358,469
(-4.78%↓ Y/Y)
Total current assets
$1,333,012
(11.27%↑ Y/Y)
Equipment, net
$200,461
(54.93%↑ Y/Y)
Total assets
$6,891,942
(-39.93%↓ Y/Y)
Accumulated deficit
-$114,606,653
(-10.96%↓ Y/Y)
Total liabilities and
shareholders deficit
$6,891,942
(-39.93%↓ Y/Y)
Total shareholders
deficit
-$30,830,561
(-36.58%↓ Y/Y)
Additional paid-in capital
$82,547,535
(3.03%↑ Y/Y)
Accumulated other
comprehensive income (loss)
$527,649
(603.63%↑ Y/Y)
Preferred stock
value-Series BPreferred...
$455,000
(0.00%↑ Y/Y)
Preferred stock
value-Series CPreferred...
$100,000
(0.00%↑ Y/Y)
Preferred stock
value-Series APreferred...
$74,416
(0.00%↑ Y/Y)
Common shares, 0.0001
par value...
$70,869
(6.97%↑ Y/Y)
Treasury shares, 0.0001
par value 6,230,761...
$623
Total liabilities
$37,722,503
(10.80%↑ Y/Y)
Total current
liabilities
$32,569,584
(12.49%↑ Y/Y)
Liability for
right-of-use building
$4,817,775
(-5.40%↓ Y/Y)
Loans payable to
related parties
$335,144
(-96.63%↓ Y/Y)
Loans payable to
related parties,...
$13,075,235
Accounts payable and
accrued liabilities
$10,476,912
(91.96%↑ Y/Y)
Derivative conversion
feature
$2,808,176
(397.86%↑ Y/Y)
Accrued interest
$2,193,967
(-43.24%↓ Y/Y)
Obligation to issue shares
$1,090,155
(-36.88%↓ Y/Y)
Convertible notes
$1,017,004
(-21.66%↓ Y/Y)
Liability for
right-of-use building,...
$964,994
(-3.99%↓ Y/Y)
Royalty payable
$483,554
(757.29%↑ Y/Y)
Notes payable
$423,345
(-12.51%↓ Y/Y)
Deferred revenue
$36,242
Back
Back
Balance Sheet
CANNAPHARMARX, INC. (CPMD)
CANNAPHARMARX, INC. (CPMD)
source: myfinsight.com